NRG-GU006: A PHASE II, DOUBLE-BLINDED, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SALVAGE RADIOTHERAPY WITH OR WITHOUT ENHANCED ANTI-ANDROGEN THERAPY WITH APALUTAMIDE IN RECURRENT PROSTATE CANCER (BALANCE)
Evaluating the addition of apalutamide to radiotherapy for men with recurrent prostate cancer
This Study is
No Longer Enrolling
Adult
II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Treatment
Greeley Hospital
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital
Poudre Valley Hospital
University of Colorado Hospital
Protocol Number: 18-1742
More information available at ClinicalTrials.gov: NCT03371719
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers